The Lamzede market is witnessing steady growth over the forecast period, supported by expansion of newborn screening programs, development of next-generation enzyme therapies.
Read More
The Kynamro market is witnessing steady growth over the forecast period, supported by replacement by next-generation lipid therapies, increased competition from novel biologics.
Read More
The Kymriah market is witnessing steady growth over the forecast period, supported by growing pipeline of car-t indications, increasing adoption in adult patient populations.
Read More
The Krystexxa market is witnessing steady growth over the forecast period, supported by growing refractory gout patient pool, increased referral to specialty clinics.
Read More
The Kovaltry market is witnessing steady growth over the forecast period, supported by increasing adoption of prophylaxis therapy, growth in home infusion programs.
Read More
The Koate-DVI market is witnessing steady growth over the forecast period, supported by increasing focus on patient friendly oral drugs, growth in modified release formulations.
Read More
The Kinrix market is witnessing steady growth over the forecast period, supported by expansion of booster dose coverage, increasing school immunization mandates.
Read More
The Kinlytic market is witnessing steady growth over the forecast period, supported by continued demand for emergency thrombolysis, growth in cardiovascular emergencies.
Read More
The Kineret market is witnessing steady growth over the forecast period, supported by growing recognition of autoinflammatory diseases, expansion into new indications.
Read More
The Kimmtrak market is witnessing steady growth over the forecast period, supported by expansion into additional melanoma indications, growth in targeted immunotherapies.
Read More